| 拉米夫定联合胸腺肽治疗慢性乙型肝炎25例临床分析 |
| |
| 引用本文： | 陆竹,魏瑞华,王锦海. 拉米夫定联合胸腺肽治疗慢性乙型肝炎25例临床分析[J]. 中国医药导刊, 2005, 7(4): 286-287 |
| |
| 作者姓名： | 陆竹 魏瑞华 王锦海 |
| |
| 作者单位： | 山东省枣庄市峄城区人民医院,山东,277300 |
| |
| 摘 要： | 目的:观察拉米夫定联合胸腺肽治疗慢性乙型肝炎的效果.方法:将50例慢性乙型肝炎病人,随机分为治疗组25例,给予拉米夫定100mg,qd疗程12月;胸腺肽160mg,每周2次,疗程6月.对照组25例,给予拉米夫定100mg,qd疗程12月.结果:治疗组总有效率88.0%;对照组总有效率56.0%,两组总有效率相比有显著差异性(x2=6.39,P＜0.05).结论:拉米夫定联合胸腺肽治疗慢性乙型肝炎疗效肯定,可作为一种有效的治疗方法.
|
| 关 键 词： | 拉米夫定 胸腺肽 慢性乙型肝炎 |
The Clinical Analysis of 25 Chronic Hepatitis B Patients Treated with Lamivudine and Thymic Peptide |
| |
| LU Zhu,Wei Rui-hua,WANG Jin-hai. The Clinical Analysis of 25 Chronic Hepatitis B Patients Treated with Lamivudine and Thymic Peptide[J]. Chinese Journal of Medicinal Guide, 2005, 7(4): 286-287 |
| |
| Authors: | LU Zhu Wei Rui-hua WANG Jin-hai |
| |
| Abstract: | Objective: To investigate the clinical effects of Lamivudine and Thymic Peptide treating Chronic Hepatitis B Patients. Methods: 50 patients were divided into two groups randomly. Treatment group 25 patients were treated with Lamivudine and Thymic Peptide; Control group 25 patients were treated with Lamivudine only. Results: The effective rate was 88.0% in treatment group and 56.0% in control group. The difference was very significant between two group (X~2=6.39,P<0.05).Conclusion: Lamivudine and Thymic Peptide have significandly effects on Chronic Hepatitis B patients. |
| |
| Keywords: | Lamivudine Thymic Peptide Chronic Hepatitis B |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
